Brazilian Organization Files Opposition To Gilead’s Antiretroviral Patent Application In India
Jul 4th 2008Drug InformationPharma Industry
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science’s antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil’s ability to produce and access affordable generic versions of the drug, India’s
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
